Piperazine salts as d3/d2 antagonists

Piperazine salts as d3/d2 antagonists

  • CN 101,679,315 B
  • Filed: 05/13/2008
  • Issued: 06/12/2013
  • Est. Priority Date: 05/11/2007
  • Status: Active Grant
First Claim
Patent Images

1. the trans 4-{2-[4-of crystallization (2,3-dichlorophenyl)-piperazine-1-yl]-ethyl }-N, N-dimethylamino formyl radical-cyclohexylamine hydrochloride anhydride, it has basically x-ray diffractogram of powder shape as shown in Figure 3.

View all claims
    ×
    ×

    Thank you for your feedback

    ×
    ×